Cyclophosphamide and Polaramine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cyclophosphamide (cyclophosphamide) and Polaramine (dexchlorpheniramine maleate). Common drug interactions include alanine aminotransferase increased among females and neutropenia among males.
The phase IV clinical study analyzes what interactions people have when they take Cyclophosphamide and Polaramine. It is created by eHealthMe based on reports of 554 people who take the same drugs from the FDA, and is updated regularly.
What is Cyclophosphamide?
Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.
What is Polaramine?
Polaramine has active ingredients of dexchlorpheniramine maleate. It is often used in allergic rhinitis. eHealthMe is studying from 10,531 Polaramine users. Check the latest studies of Polaramine.
554 people who take Cyclophosphamide and Polaramine together, and have interactions are studied.
What are the common drug interactions of Cyclophosphamide and Polaramine, by gender? *
What are the common drug interactions of Cyclophosphamide and Polaramine, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Cyclophosphamide and Polaramine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cyclophosphamide (185,240 reports)
- Polaramine (10,531 reports)
Browse all drug interactions of Cyclophosphamide and Polaramine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cyclophosphamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Polaramine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cyclophosphamide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Polaramine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on cyclophosphamide and dexchlorpheniramine maleate (the active ingredients of Cyclophosphamide and Polaramine, respectively), and Cyclophosphamide and Polaramine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Allopurinol cause Pleural Disorder? - 3 seconds ago
- Could Lithium Carbonate cause Balance Disorder? - 9 seconds ago
- Could Darzalex cause Multiple Myeloma? - 16 seconds ago
- Low Density Lipoprotein Increased and Injection Site Haemorrhage - 20 seconds ago
- Could Benadryl cause Vein Discoloration? - 36 seconds ago
- Drug interactions of Omeprazole and Opticrom - 36 seconds ago
- Could Chantix cause Bone Disorder? - 56 seconds ago
- Drug interactions of Neoprofen and Humulin R - a minute ago
- Could Claritin-D 24 Hour cause Stroke? - a minute ago
- Drug interactions of Latanoprost and Zantac - a minute ago